Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVA Inventiva S.A.

未开盘 02-12 16:00:00 EST

6.20

+0.01

+0.16%

盘后6.20

+0.000.00%

16:00 EST

最高6.37	最低6.03	成交量21.15万
今开6.36	昨收6.19	日振幅5.49%
总市值11.85亿	流通市值7.07亿	总股本1.91亿
成交额130.49万	换手率0.19%	流通股本1.14亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":6.2,"timestamp":1770930000000,"preClose":6.19,"halted":0,"volume":211461,"hourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.2,"latestTime":"16:00 EST","volume":47,"amount":291.40000000000003,"timestamp":1770930002459,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0016155088852988345,"floatShares":113999999,"shares":191077498,"eps":-4.2552,"marketStatus":"未开盘","change":0.01,"latestTime":"02-12 16:00:00 EST","open":6.36,"high":6.37,"low":6.03,"amount":1304922.595647,"amplitude":0.054927,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.2552,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770973200000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":6.19,"preHourTrading":{"tag":"盘前","latestPrice":6.38,"preClose":6.19,"latestTime":"09:29 EST","volume":656,"amount":4118.059679999999,"timestamp":1770906541010,"change":0.19,"changeRate":0.030695,"amplitude":0.030695},"postHourTrading":{"tag":"盘后","latestPrice":6.2,"preClose":6.2,"latestTime":"16:00 EST","volume":47,"amount":291.40000000000003,"timestamp":1770930002459,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.413166},"requestUrl":"/m/hq/s/IVA/tweets","defaultTab":"tweets","newsList":[{"id":"2610662075","title":"Inventiva Sa盘中异动 早盘大幅上涨5.05%报6.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610662075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610662075?lang=zh_cn&edition=full","pubTime":"2026-02-10 22:39","pubTimestamp":1770734369,"startTime":"0","endTime":"0","summary":"北京时间2026年02月10日22时39分，Inventiva Sa股票出现波动，股价大幅拉升5.05%。截至发稿，该股报6.24美元/股，成交量13.3951万股，换手率0.06%，振幅2.02%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.08%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223929a4940c3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210223929a4940c3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2605112034","title":"Inventiva Sa盘中异动 股价大跌7.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605112034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605112034?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:33","pubTimestamp":1768919611,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时33分，Inventiva Sa股票出现异动，股价快速下挫7.83%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为1.55%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223331a44183b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223331a44183b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2583689679","title":"Inventiva Sa盘中异动 股价大涨5.24%报4.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583689679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583689679?lang=zh_cn&edition=full","pubTime":"2025-11-15 00:41","pubTimestamp":1763138490,"startTime":"0","endTime":"0","summary":"北京时间2025年11月15日00时41分，Inventiva Sa股票出现异动，股价快速拉升5.24%。截至发稿，该股报4.02美元/股，成交量15.5819万股，换手率0.11%，振幅7.59%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.29%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115004130a6f9f55c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115004130a6f9f55c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2583208582","title":"Inventiva Sa盘中异动 股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583208582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583208582?lang=zh_cn&edition=full","pubTime":"2025-11-13 01:02","pubTimestamp":1762966978,"startTime":"0","endTime":"0","summary":"北京时间2025年11月13日01时02分，Inventiva Sa股票出现异动，股价急速上涨5.94%。截至发稿，该股报4.10美元/股，成交量3.4046万股，换手率0.02%，振幅5.68%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.53%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111301025897652eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111301025897652eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2578193522","title":"Inventiva Sa盘中异动 早盘股价大涨5.96%报6.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578193522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578193522?lang=zh_cn&edition=full","pubTime":"2025-10-27 22:46","pubTimestamp":1761576386,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日22时46分，Inventiva Sa股票出现波动，股价快速拉升5.96%。截至发稿，该股报6.57美元/股，成交量2.7456万股，换手率0.02%，振幅4.67%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.35%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027224626a477e2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027224626a477e2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2577640465","title":"Inventiva Sa盘中异动 股价大涨5.61%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577640465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577640465?lang=zh_cn&edition=full","pubTime":"2025-10-23 23:36","pubTimestamp":1761233807,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日23时36分，Inventiva Sa股票出现异动，股价快速拉升5.61%。截至发稿，该股报5.65美元/股，成交量3.7066万股，换手率0.03%，振幅6.64%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.04%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023233648a6ca59a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023233648a6ca59a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2576058964","title":"Inventiva Sa盘中异动 大幅下跌8.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576058964","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576058964?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:32","pubTimestamp":1760621524,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时32分，Inventiva Sa股票出现波动，股价大幅下跌8.04%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Praxis Precision Medicines, Inc.、Whitehawk Therapeutics, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Theriva Biologics, Inc.、Whitehawk Therapeutics, Inc.、Adaptimmune Therapeutics Plc较为活跃，换手率分别为98.56%、73.59%、27.60%，振幅较大的相关个股有Citius Pharmaceuticals, Inc.、Praxis Precision Medicines, Inc.、Whitehawk Therapeutics, Inc.，振幅分别为25.50%、22.67%、13.80%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213204a6bd1f83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213204a6bd1f83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2569979051","title":"Inventiva Sa盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569979051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569979051?lang=zh_cn&edition=full","pubTime":"2025-09-23 03:21","pubTimestamp":1758568860,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日03时21分，Inventiva Sa股票出现异动，股价大幅拉升5.13%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Mbx Biosciences, Inc.、Qualigen Therapeutics, Inc.、Kodiak Sciences Inc涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为3475.44%、161.77%、76.92%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为144.19%、86.84%、67.16%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923032101a72fecb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923032101a72fecb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2518758972","title":"Inventiva Sa盘中异动 急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518758972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518758972?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:46","pubTimestamp":1741614375,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时46分，Inventiva Sa股票出现波动，股价大幅下跌5.14%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2547.15%、588.39%、88.73%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021461598a2a0e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021461598a2a0e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2517167355","title":"Inventiva Sa盘中异动 大幅拉升5.91%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517167355?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:07","pubTimestamp":1741277227,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时07分，Inventiva Sa股票出现异动，股价急速上涨5.91%。截至发稿，该股报2.92美元/股，成交量1471股，换手率0.00%，振幅5.43%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.35%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000707989ec6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000707989ec6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2516677303","title":"Inventiva Sa盘中异动 早盘股价大跌7.09%报2.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677303?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098745,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Inventiva Sa股票出现异动，股价大幅下跌7.09%。截至发稿，该股报2.75美元/股，成交量1.0787万股，换手率0.02%，振幅1.01%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.25%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223225abe7efc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223225abe7efc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2516659446","title":"Inventiva Sa盘中异动 股价大跌5.36%报3.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516659446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516659446?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:35","pubTimestamp":1741023323,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日01时35分，Inventiva Sa股票出现波动，股价快速下挫5.36%。截至发稿，该股报3.00美元/股，成交量3418股，换手率0.01%，振幅4.73%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.26%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040135239637d5f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040135239637d5f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2516376064","title":"Inventiva Sa盘中异动 大幅下跌6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516376064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516376064?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:48","pubTimestamp":1740757736,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时48分，Inventiva Sa股票出现异动，股价快速下跌6.13%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1937.50%、451.01%、351.46%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、41.62%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228234857abe0fcd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228234857abe0fcd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2514385514","title":"Inventiva Sa盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385514?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:40","pubTimestamp":1740667200,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时40分，Inventiva Sa股票出现异动，股价快速跳水6.34%。截至发稿，该股报2.96美元/股，成交量151股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.68%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224001a2567c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224001a2567c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2514153950","title":"Inventiva Sa盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514153950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514153950?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:07","pubTimestamp":1740496061,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时07分，Inventiva Sa股票出现异动，股价急速上涨5.15%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.95%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230741abdc8773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230741abdc8773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2512162557","title":"Inventiva Sa盘中异动 股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512162557?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:04","pubTimestamp":1739894679,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时04分，Inventiva Sa股票出现波动，股价急速上涨5.58%。截至发稿，该股报2.65美元/股，成交量7354股，换手率0.01%，振幅4.38%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.83%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000439a24ac161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000439a24ac161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2511579854","title":"Inventiva Sa盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511579854?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:02","pubTimestamp":1739473344,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时02分，Inventiva Sa股票出现异动，股价急速上涨5.42%。截至发稿，该股报2.53美元/股，成交量2758股，换手率0.01%，振幅5.62%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.09%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214030224abcde691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214030224abcde691&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0},{"id":"2510738033","title":"Inventiva Sa盘中异动 早盘股价大跌8.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510738033","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510738033?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:34","pubTimestamp":1739284461,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时34分，Inventiva Sa股票出现波动，股价急速下跌8.93%。截至发稿，该股报2.23美元/股，成交量15股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.96%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223422961f4825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223422961f4825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OCEA","IVA"],"gpt_icon":0},{"id":"2510696908","title":"Inventiva Sa盘中异动 早盘快速下挫5.23%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510696908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510696908?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:23","pubTimestamp":1739200998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时23分，Inventiva Sa股票出现异动，股价大幅跳水5.23%。截至发稿，该股报2.31美元/股，成交量226股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.16%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232318961e0b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210232318961e0b45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IVA"],"gpt_icon":0},{"id":"2509625328","title":"Inventiva Sa盘中异动 下午盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509625328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509625328?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:01","pubTimestamp":1738785698,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时01分，Inventiva Sa股票出现波动，股价急速拉升5.02%。截至发稿，该股报2.59美元/股，成交量1840股，换手率0.00%，振幅3.45%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为2.46%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040138a23abf3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206040138a23abf3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IVA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":0.069},{"period":"1month","weight":0.0858},{"period":"3month","weight":0.55},{"period":"6month","weight":0.422},{"period":"1year","weight":1.5833},{"period":"ytd","weight":0.3333}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年，并于2016年注册成立。该公司是一家临床阶段的生物制药公司，致力于开发口服小分子疗法，以治疗非酒精性脂肪性肝炎或NASH，粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道，该发现引擎具有广泛的专有分子库，一个全资研发设施以及一个在开发针对核受体，转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098872},{"month":2,"riseRate":0.666667,"avgChangeRate":0.036081},{"month":3,"riseRate":0,"avgChangeRate":-0.105896},{"month":4,"riseRate":0.2,"avgChangeRate":-0.08167},{"month":5,"riseRate":0.6,"avgChangeRate":0.107821},{"month":6,"riseRate":0.2,"avgChangeRate":-0.118686},{"month":7,"riseRate":0.4,"avgChangeRate":-0.068338},{"month":8,"riseRate":0.333333,"avgChangeRate":0.149729},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0365},{"month":10,"riseRate":0.666667,"avgChangeRate":0.071747},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.025201},{"month":12,"riseRate":0.833333,"avgChangeRate":0.034174}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}